glp-1 drug manufacturers Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Agonists: A Comprehensive Overview
Description
RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Big picture view: The rapid rise in GLP-1 usage continues to align with broader improvements in national health, particularly aiding in lowering obesity rates
The impact of GLP-1 use extends beyond just calorie-dense items, with most food categories experiencing declines in purchases
bmjopen-2023-083550supp001.pdf (228.5KB, pdf) Pregnancy outcomes Table 2 presents the proportions of offspring with major birth defects in pregnancies exposed to GLP1-RA agonists, the reference group with diabetes and the overweight/obese reference group
Who is at risk of developing NAION while using Mounjaro
Competitive Landscape 8.1
& Young, A
